Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7417809> ?p ?o }
Showing triples 1 to 41 of
41
with 100 triples per page.
- Q7417809 subject Q8301163.
- Q7417809 subject Q8403399.
- Q7417809 abstract "Sangamo BioSciences (NASDAQ: SGMO) is a clinical stage biopharmaceutical company involved in gene therapy that is researching ways of commercializing Zinc finger nucleases which modify a cell's DNA at an exact location thereby correcting or disrupting a specific gene.Sangamo BioSciences' lead therapy, SB-728, is a potential functional cure for HIV/AIDS. SB-728 works by removing some of the immune cells from the patient's blood that HIV attacks. The blood is sent to a lab which applies the SB-728 treatment to the patient's immune cells. The treatment removes the protein gateway on the immune cells that HIV needs to infect. The treated cells are then infused back into the patient whereby they reproduce and take over as HIV attacks and kills the non-treated cells. The treated, resistant cells thereby control the HIV infection and thus cures the patient from opportunistic infections that result from HIV. Recent published data further support the company's ongoing progress which has been described as "a major step toward immunological functional control of HIV."".
- Q7417809 industry Q864601.
- Q7417809 locationCity Q495377.
- Q7417809 locationCountry Q30.
- Q7417809 numberOfEmployees "84".
- Q7417809 type Q891723.
- Q7417809 wikiPageExternalLink 66655208-sangamo-gene-tests-inspired-by-one-man-s-aids-cure.html.
- Q7417809 wikiPageExternalLink the-face-of-the-cure.
- Q7417809 wikiPageExternalLink new-hope-of-a-cure-for-hiv.html?pagewanted=all.
- Q7417809 wikiPageExternalLink www.sangamo.com.
- Q7417809 wikiPageExternalLink www.sangamo.com.
- Q7417809 wikiPageExternalLink Targeting-DNA.
- Q7417809 wikiPageWikiLink Q12199.
- Q7417809 wikiPageWikiLink Q204773.
- Q7417809 wikiPageWikiLink Q30.
- Q7417809 wikiPageWikiLink Q495377.
- Q7417809 wikiPageWikiLink Q8301163.
- Q7417809 wikiPageWikiLink Q8403399.
- Q7417809 wikiPageWikiLink Q864601.
- Q7417809 wikiPageWikiLink Q891723.
- Q7417809 homepage www.sangamo.com.
- Q7417809 industry Q864601.
- Q7417809 locationCity Q495377.
- Q7417809 locationCountry Q30.
- Q7417809 name "Sangamo BioSciences".
- Q7417809 numEmployees "84".
- Q7417809 type Q891723.
- Q7417809 type Organization.
- Q7417809 type Agent.
- Q7417809 type Company.
- Q7417809 type Organisation.
- Q7417809 type Agent.
- Q7417809 type SocialPerson.
- Q7417809 type Thing.
- Q7417809 type Q43229.
- Q7417809 comment "Sangamo BioSciences (NASDAQ: SGMO) is a clinical stage biopharmaceutical company involved in gene therapy that is researching ways of commercializing Zinc finger nucleases which modify a cell's DNA at an exact location thereby correcting or disrupting a specific gene.Sangamo BioSciences' lead therapy, SB-728, is a potential functional cure for HIV/AIDS. SB-728 works by removing some of the immune cells from the patient's blood that HIV attacks.".
- Q7417809 label "Sangamo BioSciences".
- Q7417809 homepage www.sangamo.com.
- Q7417809 name "Sangamo BioSciences".